Cytogenetic analysis can provide diagnostic and prognostic information critical to effective treatment decision making for oncology patients and relies on having the right diagnostic information from the best available technology.
An extensive portfolio of tests and a wide range of methodologies, coupled with high success rates and analytical and interpretive expertise, means we can offer a flexible service which meets the demands of oncology patient management.
Cytogenetic techniques
The conventional method of cytogenetic analysis involves processing cells from fresh tissue samples containing viable tumour cells in order to produce a G-banded karyotype.
FISH analysis targets specific genetic sequences; as it does not require dividing cells, it can be performed on a wider range of sample types, including formalin-fixed paraffin-embedded (FFPE) tissue sections and slides prepared using liquid-based cytology techniques.
Sample information
|
Liquid samples |
|
|
FFPE |
|
|
UroVysion FISH |
|
Reporting times:
Urgent: 95% of samples reported within 14
calendar days.
Routine: 95% of samples reported within 21
calendar days.
Test information
For disease specific test information, download our test guide. Tests can be ordered by completing the request form here and all samples should adhere to sample transport requirements.
For key contacts and hours of operation visit the department key contacts page.